Gurpal Singh

Chandigarh University, Panjab University

Papers

Total Citations

H-Index

About

Gurpal Singh is a leading voice in pharmaceutical nanotechnology, with a focused research agenda that bridges drug delivery, cancer therapy, and nanomedicine. His most cited work, a 2019 review on the status of nanotechnology in pharmaceutical sciences (11 citations), establishes the foundational importance of particle size reduction for improving drug stability, bioavailability, and controlled release—a critical unit operation in modern pharmacy. Building on this, his 2023 review on the theragnostic approach from nanoparticles to nanobots (6 citations) tackles one of medicine’s greatest challenges: cancer. Singh highlights how nanotechnology overcomes the inherent limitations of conventional cancer therapeutics, offering a dual diagnostic and therapeutic platform that targets tumors with unprecedented precision. His work systematically charts the evolution from simple nanoparticles to sophisticated nanobots, emphasizing their potential to revolutionize cancer treatment. With a clear trajectory from fundamental pharmaceutical science to advanced cancer theragnostics, Singh’s contributions are shaping the next generation of smart, targeted drug delivery systems, making him a key researcher for students and scientists interested in the translational future of nanomedicine.